# BK channels are indispensable for endothelial function in small pulmonary arteries

**Authors:** Divya Guntur, Dusan Jeremic, Reka Csaki, Oleh Myronenko, Valentina Biasin, Dagmar Kolb, Laura Michalick, Wolfgang M. Kuebler, Peter Enyedi, Horst Olschewski, Andrea Olschewski, Chandran Nagaraj

PMC · DOI: 10.1186/s12964-025-02436-0 · Cell Communication and Signaling : CCS · 2025-10-21

## TL;DR

This study shows that BK channels are crucial for proper endothelial function in small pulmonary arteries and their dysfunction contributes to pulmonary hypertension.

## Contribution

The study reveals a novel role of BK channels in endothelial calcium signaling and identifies their downregulation in IPAH as a new pathologic mechanism.

## Key findings

- BK channel absence in mice impairs acetylcholine-induced vasodilation and mimics hypoxia-induced endothelial dysfunction.
- BK channels in human PAECs are significantly downregulated in IPAH patients and their inhibition disrupts NO production and angiogenesis.
- BK channels colocalize with Piezo-1 and their absence impairs calcium influx, affecting endothelial signaling.

## Abstract

Pulmonary hypertension (PH) is a progressive vascular disease that severely compromises quality of life and survival. The pulmonary endothelium plays a pivotal role in vascular homeostasis through complex signalling networks involving ion channels that respond to ionic imbalance (e.g. Na+, K+, Ca2+) and mechanical stimuli (e.g. via Piezo, TRPC, TRPV channels). While large-conductance calcium-activated potassium channels (BK channels), in pulmonary artery smooth muscle cells promote vasorelaxation and attenuate PH, their role in endothelial function is poorly defined. This study investigates the contribution of endothelial BK channels to pulmonary vascular signaling and their potential as therapeutic targets in PH.

Human lung tissue samples from patients with idiopathic pulmonary arterial hypertension (IPAH) and healthy donors were assessed for BK channel expression by qPCR, Western blot and immunofluorescence staining. BK channel activity in human pulmonary artery endothelial cells was evaluated through patch-clamp recordings. In vivo, BK knockout (BK KO) mice and hypoxia-exposed wild-type mice were used to study endothelial dysfunction and vascular remodeling. Cellular metabolism was analyzed using oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), mitochondrial membrane potential and ROS were assessed by live cell imaging while ex vivo vasoreactivity was assessed via wire myography.

Wild type mice exposed to hypoxia (7 and 28 days) exhibited increased right ventricular systolic pressure (RVSP) and endothelial dysfunction with reduced BK channel function. BK KO mice showed impaired acetylcholine-induced vasodilation of pulmonary arteries, a sign of endothelial dysfunction, similar to mice exposed to hypoxia. BK KO endothelial cells displayed increased mitochondrial respiration, mitochondrial membrane hyperpolarization and increased cellular ROS production. In human PAECs (hPAECs), functional BK channels were identified and in IPAH patients, they were significantly downregulated. Pharmacological BK inhibition in hPAECs resulted in impaired nitric oxide (NO) production and uncontrolled angiogenesis. Furthermore, BK channels colocalized with Piezo-1, and their absence impaired Piezo-1-mediated calcium influx, suggesting a pivotal role in endothelial calcium signaling.

BK channels are integral to pulmonary endothelial signalling, controlling vasodilation, angiogenesis, calcium dynamics, metabolic and oxidative homeostasis. Their impairment causes endothelial dysfunction in PH, and their downregulation in IPAH highlights a novel pathologic mechanism. Restoration of BK channel function may offer a new therapeutic strategy to improve endothelial function and counteract pulmonary vascular remodelling.

The online version contains supplementary material available at 10.1186/s12964-025-02436-0.

## Linked entities

- **Proteins:** PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)), Nos1 (nitric oxide synthase 1, neuronal)
- **Diseases:** pulmonary hypertension (MONDO:0005149), idiopathic pulmonary arterial hypertension (MONDO:0001999)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Cav1 (caveolin 1, caveolae protein) [NCBI Gene 12389] {aka Cav, Cav-1}, Cav3 (caveolin 3) [NCBI Gene 12391] {aka Cav-3, M-cav}, Piezo2 (piezo-type mechanosensitive ion channel component 2) [NCBI Gene 667742] {aka 5930434P17, 9030411M15Rik, 9430028L06Rik, Fam38b, Fam38b2}, Bdkrb2 (bradykinin receptor, beta 2) [NCBI Gene 12062] {aka B(2), B2, B2R, BK-2, BK2, BK2R}, Trpv4 (transient receptor potential cation channel, subfamily V, member 4) [NCBI Gene 63873] {aka 0610033B08Rik, OTRPC4, Trp12, VR-OAC, VRL-2, VROAC}, CAV1 (caveolin 1) [NCBI Gene 281040], PIEZO1 (piezo type mechanosensitive ion channel component 1) [NCBI Gene 789183], Kcnk3 (potassium channel, subfamily K, member 3) [NCBI Gene 16527] {aka TASK, Task-1, cTBAK-1}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 281181] {aka GAPD}, MIR29B1 (microRNA 29b-1) [NCBI Gene 407024] {aka MIRN29B1, miR-29b, miRNA29B1, mir-29b-1}, Nos3 (nitric oxide synthase 3, endothelial cell) [NCBI Gene 18127] {aka 2310065A03Rik, Nos-3, eNOS, ecNOS}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780] {aka DHS, ER, FAM38A, LMPH3, LMPHM6, Mib}, KCNMA1 (potassium calcium-activated channel subfamily M alpha 1) [NCBI Gene 3778] {aka BKTM, CADEDS, IEG16, KCa1.1, LIWAS, MaxiK}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, ACTBP (actin beta pseudogene) [NCBI Gene 281594], Piezo1 (piezo-type mechanosensitive ion channel component 1) [NCBI Gene 234839] {aka 9630020g22, Fam38a, mKIAA0233}, Stim1 (stromal interaction molecule 1) [NCBI Gene 20866] {aka SIM}, Pvr (poliovirus receptor) [NCBI Gene 52118] {aka 3830421F03Rik, CD155, D7Ertd458e, HVED, PVS, Taa1}, Ptgir (prostaglandin I receptor (IP)) [NCBI Gene 19222] {aka IP, PGI2}, Orai1 (ORAI calcium release-activated calcium modulator 1) [NCBI Gene 109305] {aka D730049H07Rik, Tmem142a, orai-1}, VIM (vimentin) [NCBI Gene 7431], Syt17 (synaptotagmin XVII) [NCBI Gene 110058] {aka Bk, sytXVII}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Cav2 (caveolin 2) [NCBI Gene 12390], ALB (albumin) [NCBI Gene 280717]
- **Diseases:** right ventricular hypertrophy (MESH:D017380), mPAP (MESH:D000071079), IPAH (MESH:D065627), mitochondrial dysfunction (MESH:D028361), chronic thromboembolic pulmonary hypertension (MESH:D011655), hypoxic (MESH:D002534), CTEPH (OMIM:612862), Left-sided heart disease (MESH:D006333), pulmonary vascular remodelling (MESH:D066253), cardiovascular diseases (MESH:D002318), PAH (MESH:D010661), HOX (MESH:D000860), COPD (MESH:D029424), PAs (MESH:C535377), PH (MESH:D006976), lung disease (MESH:D008171), dislocation (MESH:D004204), Pulmonary arterial hypertension (MESH:D000081029), endothelial dysfunction (MESH:D014652)
- **Chemicals:** U-46619 (MESH:D019796), ionomycin (MESH:D015759), propylene oxide (MESH:C009068), SNP (MESH:D009599), agarose (MESH:D012685), H2DCFDA (MESH:C110400), D-glucose (MESH:D005947), BCA (MESH:C047117), 4',6-diamidino-2-phenylindole (MESH:C007293), methanol (MESH:D000432), pyruvate (MESH:D019289), HCl (MESH:D006851), Acetylcholine (MESH:D000109), prostacyclin (MESH:D011464), nitrogen (MESH:D009584), glutaraldehyde (MESH:D005976), Formalin (MESH:D005557), NaOH (MESH:D012972), SDS (MESH:D012967), lipid (MESH:D008055), Calcium (MESH:D002118), Trizol (MESH:C411644), 3-(N-morpholino)propanesulfonic acid (MESH:C008550), antimycinA (MESH:D000968), cacodylate (MESH:D002101), 2-DG (MESH:D003847), glycine (MESH:D005998), ITX (MESH:C403901), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (MESH:C410687), Na+ (MESH:D012964), Magnesium chloride (MESH:D015636), Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (MESH:C108897), Iberiotoxin (MESH:C064719), Fura-2-acetoxymethyl ester (-), 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (MESH:C503301), NO (MESH:D009569), L-glutamine (MESH:D005973), EGTA (MESH:D004533), ROS (MESH:D017382), PVDF (MESH:C024865), oligomycin (MESH:D009840), antimycin (MESH:C032456), O2 (MESH:D010100), K+ (MESH:D011188), ethanol (MESH:D000431), streptomycin (MESH:D013307), EDTA (MESH:D004492), CaCl2 (MESH:D002122), DMSO (MESH:D004121), FCCP (MESH:D002259), osmium tetroxide (MESH:D009993), PFA (MESH:C003043), TCEP (MESH:C080938), Triton X-100 (MESH:D017830), penicillin (MESH:D010406), Diacylglycerol (MESH:D004075), Tween 20 (MESH:D011136), Phosphate (MESH:D010710), isoflurane (MESH:D007530), NaCl (MESH:D012965)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), PAECs — Bos taurus (Bovine), Spontaneously immortalized cell line (CVCL_4130), IPAH — Homo sapiens (Human), Finite cell line (CVCL_3718), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), hPAECs — Homo sapiens (Human), Finite cell line (CVCL_3716)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12542031/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12542031/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12542031/full.md

---
Source: https://tomesphere.com/paper/PMC12542031